Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Blake

Showing results (851-860 of 895) with videos related to

Pageof 90
Sort By:
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 14, 2009
Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/ImmunohistochemistryJefferson Terry, Emina Emilia Torlakovic, John Garratt, et al.
Gynecologic Oncology|March 5, 2022
Variation in practice in endometrial cancer and potential for improved care and equity through molecular classificationAmy Jamieson, Jutta Huvila, Emily F Thompson, et al.
The Journal of Pathology|July 21, 2020
Synthesis of diagnostic quality cancer pathology images by generative adversarial networksAdrian B Levine, Jason Peng, David Farnell, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2023
Corrigendum to "Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death": [Modern Pathology 36 (2023) 100085]Amy Jamieson, Jutta Huvila, Derek Chiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2023
Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial CarcinomasAmy Jamieson, Lisa Vermij, Claire J H Kramer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2020
Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic TypeJennifer X Ji, Dawn R Cochrane, Basile Tessier-Cloutier, et al.
JCO Global Oncology|May 25, 2023
<i>QPOLE</i>: A Quick, Simple, and Cheap Alternative for <i>POLE</i> Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain ReactionAnne Sophie V M Van den Heerik, Natalja T Ter Haar, Lisa Vermij, et al.
Nature Communications|March 25, 2023
Genomic characterization of DICER1-associated neoplasms uncovers molecular classesFelix K F Kommoss, Anne-Sophie Chong, Anne-Laure Chong, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific DeathAmy Jamieson, Jutta Huvila, Derek Chiu, et al.
The Journal of Pathology|August 18, 2012
Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomasMichael S Anglesio, Stefan Kommoss, Mary C Tolcher, et al.
Pageof 90

Showing results (851-860 of 895) with videos related to

Sort By:
Pageof 90
Applied Immunohistochemistry & Molecular Morphology : AIMM|April 14, 2009
Implementation of a Canadian external quality assurance program for breast cancer biomarkers: an initiative of Canadian Quality Control in immunohistochemistry (cIQc) and Canadian Association of Pathologists (CAP) National Standards Committee/ImmunohistochemistryJefferson Terry, Emina Emilia Torlakovic, John Garratt, et al.
Gynecologic Oncology|March 5, 2022
Variation in practice in endometrial cancer and potential for improved care and equity through molecular classificationAmy Jamieson, Jutta Huvila, Emily F Thompson, et al.
The Journal of Pathology|July 21, 2020
Synthesis of diagnostic quality cancer pathology images by generative adversarial networksAdrian B Levine, Jason Peng, David Farnell, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 14, 2023
Corrigendum to "Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death": [Modern Pathology 36 (2023) 100085]Amy Jamieson, Jutta Huvila, Derek Chiu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 29, 2023
Clinical Behavior and Molecular Landscape of Stage I p53-Abnormal Low-Grade Endometrioid Endometrial CarcinomasAmy Jamieson, Lisa Vermij, Claire J H Kramer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2020
Arginine Depletion Therapy with ADI-PEG20 Limits Tumor Growth in Argininosuccinate Synthase-Deficient Ovarian Cancer, Including Small-Cell Carcinoma of the Ovary, Hypercalcemic TypeJennifer X Ji, Dawn R Cochrane, Basile Tessier-Cloutier, et al.
JCO Global Oncology|May 25, 2023
<i>QPOLE</i>: A Quick, Simple, and Cheap Alternative for <i>POLE</i> Sequencing in Endometrial Cancer by Multiplex Genotyping Quantitative Polymerase Chain ReactionAnne Sophie V M Van den Heerik, Natalja T Ter Haar, Lisa Vermij, et al.
Nature Communications|March 25, 2023
Genomic characterization of DICER1-associated neoplasms uncovers molecular classesFelix K F Kommoss, Anne-Sophie Chong, Anne-Laure Chong, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 14, 2023
Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific DeathAmy Jamieson, Jutta Huvila, Derek Chiu, et al.
The Journal of Pathology|August 18, 2012
Molecular characterization of mucinous ovarian tumours supports a stratified treatment approach with HER2 targeting in 19% of carcinomasMichael S Anglesio, Stefan Kommoss, Mary C Tolcher, et al.
Pageof 90